Seattle-based biotech startup Kineta today announced that it won a $ 7.2 million award to develop an antiviral drug therapy for treating Lassa haemorrhagic fever.
The money comes from The Wellcome Trust, a London-based...
Cyberattacks have moved beyond the simple virus; now they exploit holes in security systems in ways that are nearly impossible to detect with traditional methods.
But the U.S. Department of Defense just awarded the University...
If you are one of the 1.2 million Americans living with HIV, your treatment options are basically limited to taking a regimen of antiviral pills.
More
Comments are closed
